...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China.
【24h】

Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China.

机译:1,078例肝细胞癌患者的肝移植结局:中国上海的多中心经验。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate current selection criteria for patients undergoing liver transplantation (LT) in response to hepatocellular carcinoma (HCC), and to analyze the prognostic factors for successful transplantation. METHODS: We evaluated the outcome of 1,078 consecutive patients with HCC from the Shanghai Multi-Center Collaborative LT Group who underwent LT over a 6-year period. Clinicopathologic data for these patients were evaluated. The prognostic significance was assessed using Kaplan-Meier survival estimates and log-rank tests. Multivariate study with Cox's proportional hazard model was used to evaluate the prognosis-relative aspects. RESULTS: We determined that expansion of Milan criteria to include: a solitary lesion < or = 9 cm in diameter, no more than three lesions with the largest < or = 5 cm, a total tumor diameter < or = 9 cm without macrovascular invasion, lymph node invasion and extrahepatic metastasis (referred to as the "Shanghai criteria"), resulted in overall survival (OS) and disease-free survival (DFS) rates that were similar to the Milan criteria. Multivariate analysis using the Cox proportional hazards regression model showed that the Child-Pugh-Turcotte classification (P = 0.010, 0.000), tumor differentiation (P = 0.001, 0.000), tumor size (P = 0.000, 0.000) and number (P = 0.014, 0.016), macrovascular invasion (P = 0.022, 0.000) and alpha-fetoprotein (AFP) levels (P = 0.031, 0.003) were independent predictors of OS and DFS, while post-LT chemotherapy (OS, P = 0.000) and tumor encapsulation (DFS, P = 0.038) were independent predictors of OS or DFS. CONCLUSION: Shanghai criteria expanded the current criteria while maintaining similar survival.
机译:目的:评估针对肝细胞癌(HCC)接受肝移植(LT)的患者的当前选择标准,并分析成功移植的预后因素。方法:我们评估了来自上海多中心协作性LT组的1078例连续6年进行LT的HCC患者的结局。对这些患者的临床病理数据进行了评估。使用Kaplan-Meier生存评估和对数秩检验评估预后的意义。采用Cox比例风险模型进行多变量研究以评估预后相关方面。结果:我们确定米兰标准的扩展范围包括:直径<或= 9 cm的单个病变,最大<或= 5 cm的不超过三个病变,总肿瘤直径<或= 9 cm且无大血管侵犯,淋巴结浸润和肝外转移(称为“上海标准”)导致总体生存率(OS)和无病生存率(DFS)与米兰标准相似。使用Cox比例风险回归模型进行的多变量分析显示,Child-Pugh-Turcotte分类(P = 0.010,0.000),肿瘤分化(P = 0.001、0.000),肿瘤大小(P = 0.000、0.000)和数目(P = 0.014,0.016),大血管浸润(P = 0.022,0.000)和甲胎蛋白(AFP)水平(P = 0.031,0.003)是OS和DFS的独立预测因子,而LT后化疗(OS,P = 0.000)和肿瘤包埋(DFS,P = 0.038)是OS或DFS的独立预测因子。结论:上海标准扩大了现行标准,同时维持了相似的生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号